Company ICON Public Limited Company

Equities

ICLR

IE0005711209

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sales per region

Ratings for ICON Public Limited Company

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 26/04/2024 BST			5-day change	1st Jan Change
308.3 ^USD	+2.74%		+6.97%	+8.92%

04-26	UBS Adjusts ICON Price Target to $380 From $368, Maintains Buy Rating	MT
04-25	Transcript : ICON Public Limited Company, Q1 2024 Earnings Call, Apr 25, 2024

ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Number of employees: 41,150

USD in Million	2022	Weight	2023	Weight	Delta
Outsourced Development Services 100.0 %	7,741	100.0 %	8,120	100.0 %	+4.89%

USD in Million	2022	Weight	2023	Weight	Delta
United States 40.4 %	3,575	46.2 %	3,284	40.4 %	-8.14%
Ireland 29.3 %	1,985	25.6 %	2,377	29.3 %	+19.78%
Rest of Europe 19.4 %	1,618	20.9 %	1,575	19.4 %	-2.69%
Other 10.9 %	564	7.3 %	884	10.9 %	+56.87%

Managers	Title	Age	Since
Stephen Cutler CEO	Chief Executive Officer	63	31/10/11
Brendan Brennan DFI	Director of Finance/CFO	45	31/12/05
Ciaran Murray CHM	Chairman	61	02/10/05
Tom O'Leary CTO	Chief Tech/Sci/R&D Officer	-	31/01/01
Diarmaid Cunningham ADM	Chief Administrative Officer	49	31/10/09
Gregory Licholai CTO	Chief Tech/Sci/R&D Officer	59	31/10/21
Simon Holmes CIO	Chief Investment Officer	-	30/06/05
Joe Cronin HRO	Human Resources Officer	-	31/12/13
Paul McCracken PRN	Corporate Officer/Principal	-	13/10/16
Andrew Garrett PRN	Corporate Officer/Principal	-	13/10/16

Members of the board	Title	Age	Since
John Climax FOU	Founder	71	31/05/90
Stephen Cutler CEO	Chief Executive Officer	63	31/10/11
Linda Grais BRD	Director/Board Member	68	30/06/21
Ciaran Murray CHM	Chairman	61	02/10/05
Eugene McCague BRD	Director/Board Member	65	03/10/17
Joan Garahy BRD	Director/Board Member	61	19/11/17
Julie O'Neill BRD	Director/Board Member	58	22/07/19
Rónán Murphy BRD	Director/Board Member	66	17/10/16

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	82,683,805	82,142,739 ( 99.35 %)	0	99.35 %

Name	Equities	%	Valuation
WCM Investment Management LLC 8.143 %	6,717,813	8.143 %	2 257 M $
Massachusetts Financial Services Co. 6.707 %	5,532,676	6.707 %	1 859 M $
Wellington Management Co. LLP 4.155 %	3,427,415	4.155 %	1 151 M $
Fidelity Management & Research Co. LLC 3.666 %	3,024,342	3.666 %	1 016 M $
Lazard Asset Management LLC 3.347 %	2,761,425	3.347 %	928 M $
Boston Partners Global Investors, Inc. 3.239 %	2,671,730	3.239 %	898 M $
Ninety One UK Ltd. 3.207 %	2,645,811	3.207 %	889 M $
Capital Research & Management Co. (Global Investors) 3.096 %	2,553,673	3.096 %	858 M $
Invesco Advisers, Inc. 2.383 %	1,965,902	2.383 %	660 M $
Fiduciary Trust Company International 2.042 %	1,684,269	2.042 %	566 M $

ICON plc

South County Business Park Leopardstown

18, Dublin

+353 1 291 2000

http://www.iconplc.com

address ICON Public Limited Company(ICLR)

Name	Category and Sector
ICON Clinical Research Ltd. ICON Clinical Research Ltd. Miscellaneous Commercial ServicesCommercial Services ICON Clinical Research Ltd., a subsidiary of ICON plc, is an Irish company located in Dublin. The firm provides consulting, outsourced development and commercialization services to pharmaceutical, biotechnology, medical device, government and public health organisations.	Miscellaneous Commercial Services
Icon Investments Five Unlimited Co.
ICON Clinical Research India Pvt Ltd. ICON Clinical Research India Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ICON plc, ICON Clinical Research India Pvt Ltd. is an Indian company that provides clinical research and development services. The private company is based in Chennai, India.	Miscellaneous Commercial Services
DOCS Resourcing Ltd. DOCS Resourcing Ltd. Medical/Nursing ServicesHealth Services DOCS Resourcing Ltd., a subsidiary of ICON plc, is an Irish company that provides human health services.	Medical/Nursing Services
Icon Investments (UK) Ltd.
ICON Global Treasury Unlimited Co. ICON Global Treasury Unlimited Co. Financial ConglomeratesFinance Part of ICON plc, ICON Global Treasury Unlimited Co. is a company headquartered in Ireland that provides financial services.	Financial Conglomerates
Icon Luxembourg SARL Icon Luxembourg SARL Finance/Rental/LeasingFinance Part of ICON plc, Icon Luxembourg SARL is a financial institution. The private company is based in Luxembourg, Luxembourg. Founded in 1998.	Finance/Rental/Leasing

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

308.3 USD

Average target price

354.1 USD

Spread / Average Target

+14.87%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+48.43%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B
BIO-TECHNE CORPORATION	-16.98%	10.07B

Other Biotechnology & Medical Research